My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lenalidomide Teva 7.5 mg hard capsules



Teva B.V.PA1986/051/003

Main Information

Trade NameLenalidomide Teva 7.5 mg hard capsules
Active SubstancesLenalidomide
Dosage FormCapsule, hard
Licence HolderTeva B.V.
Licence NumberPA1986/051/003

Group Information

ATC CodeL04AX Other immunosuppressants
L04AX04 lenalidomide

Status

License statusAuthorised
Licence Issued03/05/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListLenalidomide 7.5mg Capsules
Interchangeable List CodeIC0125-041-001
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print